We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Commissioner Scott Gottlieb outlined what the agency hopes to learn from an advisory committee Friday at a meeting about safety measures for transmucosal immediate-release fentanyl (TIRF) products. Read More
Medicare could save billions of dollars each year if the federal government negotiated directly with drug companies for all federal drug benefit programs including Medicare Part D, according to a new report released Wednesday by Sen. Claire McCaskill (D-Mo.). Read More
Demopoulos spent a large part of his life researching glutathione and he is credited by Molecular Defenses Corporation as inventing the free radical pathology field. Read More
Biosimilar products have been licensed in some countries as generics or as small molecule drugs with supporting data that don’t meet the WHO’s regulations. Read More
The World Health Organization (WHO) invited comments on a draft question-and-answer document that aims to clarify its 2009 guidelines on the evaluation of biosimilars. Read More